These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 1695013)

  • 1. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.
    Radomski MW; Palmer RM; Moncada S
    Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5193-7. PubMed ID: 1695013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the L-arginine:nitric oxide pathway in human platelets.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1990 Oct; 101(2):325-8. PubMed ID: 1701676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
    Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
    Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the existence and biological role of L-arginine/nitric oxide pathway in human platelets by spin-trapping/EPR studies.
    Prónai L; Ichimori K; Nozaki H; Nakazawa H; Okino H; Carmichael AJ; Arroyo CM
    Eur J Biochem; 1991 Dec; 202(3):923-30. PubMed ID: 1662618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway. Implications for vascular disease.
    Riddell DR; Graham A; Owen JS
    J Biol Chem; 1997 Jan; 272(1):89-95. PubMed ID: 8995232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of a nitric oxide-like factor from L-arginine by rat serosal mast cells: stimulation of guanylate cyclase and inhibition of platelet aggregation.
    Salvemini D; Masini E; Anggard E; Mannaioni PF; Vane J
    Biochem Biophys Res Commun; 1990 Jun; 169(2):596-601. PubMed ID: 1972620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergism between nitric oxide and hydrogen peroxide in the inhibition of platelet function: the roles of soluble guanylyl cyclase and vasodilator-stimulated phosphoprotein.
    Sabetkar M; Naseem KM; Tullett JM; Friebe A; Koesling D; Bruckdorfer KR
    Nitric Oxide; 2001 Jun; 5(3):233-42. PubMed ID: 11384196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
    Mellion BT; Ignarro LJ; Myers CB; Ohlstein EH; Ballot BA; Hyman AL; Kadowitz PJ
    Mol Pharmacol; 1983 May; 23(3):653-64. PubMed ID: 6135148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin increases guanosine-3',5'-cyclic monophosphate in human platelets. A mechanism involved in the insulin anti-aggregating effect.
    Trovati M; Massucco P; Mattiello L; Mularoni E; Cavalot F; Anfossi G
    Diabetes; 1994 Aug; 43(8):1015-9. PubMed ID: 7518780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of trilinolein on cyclic nucleotide formation in human platelets: relationship with its antiplatelet effect and nitric oxide synthesis.
    Shen YC; Hong CY
    Br J Pharmacol; 1995 Sep; 116(1):1644-8. PubMed ID: 8564231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-arginine infusion decreases platelet aggregation through an intraplatelet nitric oxide release.
    Marietta M; Facchinetti F; Neri I; Piccinini F; Volpe A; Torelli G
    Thromb Res; 1997 Oct; 88(2):229-35. PubMed ID: 9361375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-arginine modulates aggregation and intracellular cyclic 3,5-guanosine monophosphate levels in human platelets: direct effect and interplay with antioxidative thiol agent.
    Anfossi G; Russo I; Massucco P; Mattiello L; Perna P; Tassone F; Trovati M
    Thromb Res; 1999 Jun; 94(5):307-16. PubMed ID: 10379819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide from vascular smooth muscle cells: regulation of platelet reactivity and smooth muscle cell guanylate cyclase.
    Mollace V; Salvemini D; Anggard E; Vane J
    Br J Pharmacol; 1991 Nov; 104(3):633-8. PubMed ID: 1724627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet aggregation is inhibited by a nitric oxide-like factor released from human neutrophils in vitro.
    Faint RW; Mackie IJ; Machin SJ
    Br J Haematol; 1991 Apr; 77(4):539-45. PubMed ID: 1851034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men.
    Adams MR; Forsyth CJ; Jessup W; Robinson J; Celermajer DS
    J Am Coll Cardiol; 1995 Oct; 26(4):1054-61. PubMed ID: 7560599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in activating ability of human platelet guanylate cyclase during aggregation.
    Severina IS; Belushkina NN
    Biochem Int; 1992 Dec; 28(4):621-31. PubMed ID: 1362351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of endogenous L-arginine analogues on nitric oxide synthesis in platelets: role in platelet hyperaggregability in hypertension.
    de Meirelles LR; Mendes-Ribeiro AC; Santoro MM; Mendes MA; da Silva MN; Mann GE; Brunini TM
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1267-71. PubMed ID: 17973865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variations in the platelet arginine/nitric oxide pathway during the ovarian cycle in females affected by menstrual migraine.
    Sarchielli P; Tognoloni M; Russo S; Vulcano MR; Feleppa M; Malà M; Sartori M; Gallai V
    Cephalalgia; 1996 Nov; 16(7):468-75. PubMed ID: 8933990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMP-activated protein kinase (AMPK) regulates the insulin-induced activation of the nitric oxide synthase in human platelets.
    Fleming I; Schulz C; Fichtlscherer B; Kemp BE; Fisslthaler B; Busse R
    Thromb Haemost; 2003 Nov; 90(5):863-71. PubMed ID: 14597982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.